Literature DB >> 2437188

Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.

M Colombatti, V G Johnson, H A Skopicki, B Fendley, M S Lewis, R J Youle.   

Abstract

A monoclonal antibody raised against purified ricin B chain, 75/3B12, blocked ricin toxicity 30- to 100-fold in vitro. The 75/3B12 IgG and F(ab')2 blocked ricin binding to cell surface galactose-containing receptors. The 75/3B12 Fab bound ricin D with a Ka of 10(7) M-1, and this binding was blocked by asialofetuin, lactose, and N-acetylgalactosamine--molecules which interact with the ricin galactose-binding site--but not by fetuin, sucrose, or glucose. The 75/3B12 Fab contained no detectable carbohydrate and, according to several lines of evidence, did not bind ricin via Ig carbohydrate determinants. The monoclonal antibody appears to recognize a galactose-binding site on ricin D via the variable region of the antibody. The 75/3B12 Fab bound ricin E only 1/50 as well as ricin D and bound the Ricinus agglutinin only 1/80 as well as ricin D. The antibody specificity indicates that structural differences exist in the galactose-binding sites of the Ricinus communis lectins. Abrin and other lectins which bind galactose or N-acetylgalactosamine were not significantly bound by the monoclonal antibody. In vitro, the antibody blocked the nontarget toxicity of immunotoxins similarly to lactose. However, in vivo, unlike lactose, the 75/3B12 antibody protected mice from ricin toxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437188

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  A monoclonal antibody to an abrin chimera recognizing a unique epitope on abrin A chain confers protection from abrin-induced lethality.

Authors:  Meenakshi Sundaram Kumar; Anjali A Karande
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

2.  Recent advances in the development of vaccines against ricin.

Authors:  Robert N Brey; Nicholas J Mantis; Seth H Pincus; Ellen S Vitetta; Leonard A Smith; Chad J Roy
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

3.  A neutralizing antibody to the a chain of abrin inhibits abrin toxicity both in vitro and in vivo.

Authors:  Kalpana Surendranath; Anjali A Karande
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

4.  Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity.

Authors:  Feng Wu; Shaoan Fan; Frank Martiniuk; Seth Pincus; Sybille Müller; Heinz Kohler; Kam-Meng Tchou-Wong
Journal:  World J Biol Chem       Date:  2010-05-26

5.  Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity.

Authors:  Michael J Rudolph; David J Vance; Simon Kelow; Siva Krishna Angalakurthi; Sophie Nguyen; Simon A Davis; Yinghui Rong; C Russell Middaugh; David D Weis; Roland Dunbrack; John Karanicolas; Nicholas J Mantis
Journal:  Protein Eng Des Sel       Date:  2018-07-01       Impact factor: 1.650

Review 6.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Identification of a single amino acid substitution in the diphtheria toxin A chain of CRM 228 responsible for the loss of enzymatic activity.

Authors:  V G Johnson; P J Nicholls
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

8.  High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.

Authors:  Ronald T Toth; Siva Krishna Angalakurthi; Greta Van Slyke; David J Vance; John M Hickey; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

9.  Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-08-26       Impact factor: 3.641

10.  Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.

Authors:  Carolyn R McGuinness; Nicholas J Mantis
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.